BPG is committed to discovery and dissemination of knowledge
Featured Articles
12/27/2021 5:43:26 AM | Browse: 412 | Download: 1058
 |
Received |
|
2021-04-21 09:26 |
 |
Peer-Review Started |
|
2021-04-21 09:28 |
 |
To Make the First Decision |
|
|
 |
Return for Revision |
|
2021-06-24 07:42 |
 |
Revised |
|
2021-07-02 10:18 |
 |
Second Decision |
|
2021-11-16 03:29 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2021-11-18 06:43 |
 |
Articles in Press |
|
2021-11-18 06:43 |
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2021-12-16 11:06 |
 |
Publish the Manuscript Online |
|
2021-12-27 05:24 |
ISSN |
1948-5182 (online) |
Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
Website |
http://www.wjgnet.com |
Category |
Gastroenterology & Hepatology |
Manuscript Type |
Retrospective Study |
Article Title |
Liver function tests and metabolic-associated fatty liver disease: Changes in upper normal limits, does it really matter?
|
Manuscript Source |
Invited Manuscript |
All Author List |
Roberta Forlano, Benjamin H Mullish, Ameet Dhar, Robert D Goldin, Mark Thursz and Pinelopi Manousou |
Funding Agency and Grant Number |
Funding Agency |
Grant Number |
National Institute of Health Research (NIHR) Biomedical Research Centre based at Imperial College Healthcare NHS Trust and Imperial College London; NIHR Academic Clinical Lectureship |
CL-2019-21-002 |
European Association for The Study of the Liver |
PhD fellowship Juan Rodes 2018 |
|
Corresponding Author |
Pinelopi Manousou, MD, PhD, Senior Lecturer, Liver Unit/Department of Metabolism, Digestion and Reproduction, Faculty of Medicine, Imperial College London, Exhibition Road, London W2 1NY, United Kingdom. p.manousou@imperial.ac.uk |
Key Words |
Metabolic-associated fatty liver disease; Liver function tests; Alanine aminotransferase; Fibrosis; Stiffness |
Core Tip |
In the United Kingdom, the hepatologists receive increasing demand for secondary care services to investigate liver function tests (LFTs), especially with the suspicion of metabolic-associated fatty liver disease (MAFLD). With current upper normal limit (UNL), patients without liver diseases but elevated LFTs is high (27%), as well as those with significant fibrosis or metabolic-associated steato-hepatitis and normal LFTs (10%). Here, we aimed to evaluate the potential implications of changes in UNL of LFTs. Our data show that reducing the UNL would lead to an increase in overall healthcare burden. In MAFLD, the risk-stratification should rely on a combination of risk factors, rather than on LFTs alone. |
Publish Date |
2021-12-27 05:24 |
Citation |
Forlano R, Mullish BH, Dhar A, Goldin RD, Thursz M, Manousou P. Liver function tests and metabolic-associated fatty liver disease: Changes in upper normal limits, does it really matter? World J Hepatol 2021; 13(12): 2104-2112 |
URL |
https://www.wjgnet.com/1948-5182/full/v13/i12/2104.htm |
DOI |
https://dx.doi.org/10.4254/wjh.v13.i12.2104 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345